{"id":"W1527808522","doi":"10.1016/s1470-2045(15)70198-1","title":"Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Vismodegib; Basal cell carcinoma; Medicine; Interim analysis; Internal medicine; Adverse effect; Interim; Oncology; Clinical endpoint; Population; Clinical trial; Surgery; Basal cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004758566,0.001547236,0.002517605,0.000319284,0.0004004211,0.001992691,0.0006596828,0.001688349,0.004736212],"category_scores_gemma":[0.002998416,0.0004776917,0.00402406,0.0003747979,0.0008605762,0.002190612,0.0005944482,0.004548491,0.001069065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001312929,"about_ca_system_score_gemma":0.001418886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000664504,"about_ca_topic_score_gemma":0.002794705,"domain_scores_codex":[0.9987186,0.0006595723,0.00005942591,0.0001277442,0.0001000466,0.0003346559],"domain_scores_gemma":[0.9985477,0.0004346922,0.0002333279,0.0001778001,0.0001006517,0.0005057505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9050519,0.004044453,0.00420312,0.0007124312,0.003002345,0.0001108686,0.0001506887,0.002466909,0.00583871,0.0005660116,0.004250362,0.06960206],"study_design_scores_gemma":[0.7672797,0.1900757,0.01982707,0.0003533374,0.004181832,0.0003836544,0.0002412908,0.00290284,0.003577156,0.002939144,0.00812702,0.0001112204],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9710531,0.01021584,0.0017094,0.003349248,0.0007813289,0.00221396,0.004141405,0.0001664372,0.00636928],"genre_scores_gemma":[0.9792503,0.003561668,0.002771536,0.002779051,0.0002819408,0.001997909,0.005205219,0.00008623698,0.004066217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004758566,"threshold_uncertainty_score":0.02516603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07487761994898005,"score_gpt":0.3677770140280424,"score_spread":0.2928993940790623,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}